Striatal interneurons in Huntington's disease: Selective increase in the density of calretinin-immunoreactive medium-sized neurons

Movement Disorders

Volumn 11, Issue 6, 1996, Pages 619-626

  Cicchetti, Francesca ^a   Parent, André ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Basal ganglia; Calcium binding proteins; Huntington's chorea; Neurodegenerative diseases; Neuroprotection; Striatum

Indexed keywords

CALCIUM BINDING PROTEIN; CALRETININ;

ADULT; AGED; ARTICLE; ATROPHY; CASE REPORT; CELL DENSITY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MALE; PRIORITY JOURNAL;

ADULT; AGED; ATROPHY; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL COUNT; CORPUS STRIATUM; DENDRITES; FEMALE; HUMANS; HUNTINGTON DISEASE; IMMUNOENZYME TECHNIQUES; INTERNEURONS; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; REFERENCE VALUES;

EID: 0029839623     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110605     Document Type: Article

References (47)

1. Hayden MR. Huntington's chorea. Berlin: Springer-Verlag, 1981.
2. Folstein SE, Leigh J, Parhad IM, Folstein MF. The diagnosis of Huntington's disease. Neurology 1986;36:1279-1283.
3. Albin RL, Tagle DA. Genetics and molecular biology of Huntington's disease. Trends Neurosci 1995;18:11-14.
4. Albin RL, Young AB, Penney JB Jr. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
5. Heizmann CW, Braun K. Calcium regulation by calcium-binding proteins in neurodegenerative disorders. Berlin: Springer-Verlag, 1995.
6. Vonsattel JP, Meyers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44: 559-577.
7. Hedreen JC, Folstein SE. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 1995;54:105-120.
8. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB Jr, Young AB. Differential loss of striatal projection neurons in Huntington's disease. Proc Natl Acad Sci USA 1988;85: 5733-5737.
9. Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P. Preferential loss of preproenkephalin versus preprotakykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 1995;38:852-861.
10. Sapp E, Ge P, Aizawa H, et al. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 1995;64:397-404.
11. Albin RL, Reiner A, Anderson KD, et al. Preferential loss of striato-external pallidal projection neurons in presymptomatic Hutington's disease. Ann Neurol 1992;31:425-430.
12. Dawbarn D, DeQuidt ME, Emson PC. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Brain Res 1985;340:251-261.
13. Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin JB. Selective sparing of a class of striatal neurons in Huntington's disease. Science 1985;230:561-563.
14. Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson EP Jr. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 1987;46:12-27.
15. Kowall NW, Ferrante RJ, Martin JB. Patterns of cell loss in Huntington's disease. Trends Neurosci 1987;10:24-29.
16. Ferrante RJ, Beal MF, Kowall NW, Richardson EP Jr, Martin JB. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res 1987;411:162-166.
17. Rogers JH. Calretinin: a gene for a novel calcium binding protein expressed principally in neurons. J Cell Biol 1987; 105:1343-1353.
18. Schwaller B, Buchwald P, Bümcke I, Celio MR, Hunziker W. Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium 1993;14:639-648.
19. Parent A, Fortin M, Côté PY, Cicchetti F. Calcium-binding proteins in primate basal ganglia. Neurosci Res (in press).
20. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci 1995;18:527-535.
21. Bennett BD, Bolam JP. Characterization of calretinin-immunoreactive structures in the striatum of the rat. Brain Res 1993;609:137-148.
22. Figueredo-Cardenas G, Medina L, Reiner A. Calretinin is largely localized to a unique population of striatal interneurons in rats. Brain Res 1996;709:145-150.
23. Parent A, Cicchetti F, Beach TG. Calretinin-immunoreactive neurons in the human striatum. Brain Res 1995;674: 347-351.
24. Cicchetti F, Gould PV, Parent A. Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease. Brain Res 1996;730:232-237.
25. Hsu SM, Raine L, Fanger A. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem 1981;29:577-580.
26. Graveland GA, Williams RS, DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 1985;227:770-773.
27. Jacobowitz DM, Winsky L. Immunocytochemical localization of calretinin in the forebrain of the rat. J Comp Neurol 1991;304:198-218.
28. Résibois A, Rogers JH. Calretinin in the rat brain: an immunohistochemical study. Neuroscience 1992;46:101-134.
29. Fortin M, Parent A. Patches in the striatum of squirrel monkeys are enriched with calretinin fibers but devoid of calretinin cell bodies. Neurosci Lett 1994;182:51-54.
30. Selden N, Geula C, Hersh L, Mesulam MM. Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease, Neuroscience 1994;60:621-636.
31. Celio MR. Calbindin D28k and parvalbumin in the rat nervous system. Neuroscience 1990;35:375-475.
32. Parent A, Cicchetti F, Beach TG. Immunocytochemical characterization of neurons expressing calretinin in human striatum. Brain Pathol 1996;6:355.
33. Choi DW. Glutamate neurotoxicity and disease of the nervous system. Neuron 1988;1:623-634.
34. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695.
35. 2+ antagonist nimodipine, influence of aging and developmental drug treatment. Neurodegeneration 1995;4:307-314.
36. Ferrante RJ, Beal MF, Kowall NW. Mechanisms of neuronal degeneration in Huntington's disease. In: Percheron G, Féger J, McKenzie JS, eds. Basal ganglia IV. New York: Plenum; 1994:149-161.
37. Boegman RJ, Parent A. The response of striatal neuropeptide Y and cholinergic neurons to excitatory amino acid agonists. Brain Res 1988;452:219-226.
38. Parent A, Hazrati, LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 1995;20:91-127.
39. Albin RL, Greenamyre JT. Alternative excitotoxic hypotheses. Neurology 1992;42:733-738.
40. Medina L, Figueredo-Cardenas G, Reiner A. Differential abundance of superoxide dismutase in interneurons versus projection neurons and in matrix versus striosome neurons in monkey striatum. Brain Res 1996;798:59-70.
41. Hof PR, Nimchinsky EA, Celio MR, Bourras C, Morrison JH. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci Lett 1993;152: 145-148.
42. Daviss SR, Lewis DA. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatr Res 1995; 59:81-96.
43. Blümcke I, Beck H, Nitsch R, et al. Preservation of calretinin-immunoreactive neurons in the hippocampus of epilepsy patients with Ammon's horn sclerosis. J Neuropathol Exp Neurol 1996;55:329-431.
44. Parent A, Côté PY, Lavoie B. Chemical anatomy of primate basal ganglia. Prog Neurobiol 1995;46:131-197.
45. 28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease. Brain Res 1990;525:209-214.
46. Seto-Ohshima A, Emson PC, Lawson E, Mountjoy CQ, Carrasco LH. Loss of matrix calcium-binding protein-containing neurons in Huntington's disease. Lancet 1988:2: 1252-1255.
47. Ferrer I, Kulisevsky J, Gonzalez G, Escartín A, Chivite A, Casas R. Parvalbumin-immunoreactive neurons in the cerebral cortex and striatum in Huntington's disease. Neurodegeneration 1994;3:169-173.